Danaher Co. (NYSE:DHR) Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp grew its stake in Danaher Co. (NYSE:DHR) by 5.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,589,019 shares of the conglomerate’s stock after acquiring an additional 441,012 shares during the quarter. Bank of New York Mellon Corp owned about 1.19% of Danaher worth $1,971,609,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC boosted its holdings in Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Danaher by 3.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock valued at $1,417,342,000 after buying an additional 148,251 shares during the period. Fisher Asset Management LLC lifted its holdings in Danaher by 2.6% in the third quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock valued at $1,265,725,000 after acquiring an additional 116,299 shares during the last quarter. Flossbach Von Storch SE grew its position in Danaher by 1.2% in the fourth quarter. Flossbach Von Storch SE now owns 3,710,738 shares of the conglomerate’s stock worth $851,800,000 after acquiring an additional 44,490 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its position in Danaher by 17.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after acquiring an additional 535,254 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on DHR shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 price target (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Wells Fargo & Company reduced their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research note on Thursday, October 31st. Jefferies Financial Group reduced their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Finally, Citigroup decreased their price objective on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Stock Performance

Shares of Danaher stock opened at $211.23 on Tuesday. The business has a 50-day simple moving average of $226.25 and a 200-day simple moving average of $246.44. The company has a market cap of $150.97 billion, a PE ratio of 40.01, a P/E/G ratio of 2.66 and a beta of 0.83. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the business posted $2.09 EPS. On average, equities research analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 24.24%.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.